Market Exclusive

CVS Health Corporation (NYSE:CVS) reported earnings of $1.33 per share beating Walls Streets expectations.

CVS Health Corporation (NYSE:CVS) reported Q2 2017 earnings this Morning, coming in at $1.33 per share, beating Wall Street’s estimates of $1.31 per Share. Revenue for the quarter came in at $45.69 billion beating analyst estimates of $45.36 billion

Analyst Coverage For CVS Health Corporation (NYSE:CVS)
These are 7 Hold Ratings, 11 Buy Ratings .
The current consensus rating for CVS Health Corporation (NYSE:CVS) is Buy (Score: 2.61) with a consensus target price of $92.67 , a potential (17.12% upside)Recent Insider Trading for CVS Health Corporation (NYSE:CVS)

Dividend History for CVS Health Corporation (NYSE:CVS)

Recent Trading for CVS Health Corporation (NYSE:CVS) Shares of CVS Health Corporation closed the previous trading session at 76.90 down -2.17 -2.74% with 4,604,007 shares trading hands.

Exit mobile version